Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Arrayed shRNA Screening to Identify Suppressors of Anchorage-Independent Growth.

Eskiocak U.

Methods Mol Biol. 2019;1907:115-123. doi: 10.1007/978-1-4939-8967-6_9.

PMID:
30542995
2.

Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma.

Eskiocak B, McMillan EA, Mendiratta S, Kollipara RK, Zhang H, Humphries CG, Wang C, Garcia-Rodriguez J, Ding M, Zaman A, Rosales TI, Eskiocak U, Smith MP, Sudderth J, Komurov K, Deberardinis RJ, Wellbrock C, Davies MA, Wargo JA, Yu Y, De Brabander JK, Williams NS, Chin L, Rizos H, Long GV, Kittler R, White MA.

Cancer Discov. 2017 Aug;7(8):832-851. doi: 10.1158/2159-8290.CD-16-0955. Epub 2017 Apr 28.

3.

Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients.

Frankel AE, Eskiocak U, Gill JG, Yuan S, Ramesh V, Froehlich TW, Ahn C, Morrison SJ.

Neoplasia. 2017 Apr;19(4):255-260. doi: 10.1016/j.neo.2017.01.010. Epub 2017 Mar 6.

4.

Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma.

Potu H, Peterson LF, Kandarpa M, Pal A, Sun H, Durham A, Harms PW, Hollenhorst PC, Eskiocak U, Talpaz M, Donato NJ.

Nat Commun. 2017 Feb 15;8:14449. doi: 10.1038/ncomms14449.

5.

Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer.

Zhang L, Theodoropoulos PC, Eskiocak U, Wang W, Moon YA, Posner B, Williams NS, Wright WE, Kim SB, Nijhawan D, De Brabander JK, Shay JW.

Sci Transl Med. 2016 Oct 19;8(361):361ra140.

PMID:
27798265
6.

Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma.

Eskiocak U, Ramesh V, Gill JG, Zhao Z, Yuan SW, Wang M, Vandergriff T, Shackleton M, Quintana E, Frankel AE, Johnson TM, DeBerardinis RJ, Morrison SJ.

Nat Commun. 2016 Sep 29;7:13080. doi: 10.1038/ncomms13080. No abstract available.

7.

Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma.

Eskiocak U, Ramesh V, Gill JG, Zhao Z, Yuan SW, Wang M, Vandergriff T, Shackleton M, Quintana E, Johnson TM, DeBerardinis RJ, Morrison SJ.

Nat Commun. 2016 Aug 22;7:12336. doi: 10.1038/ncomms12336.

8.

RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression.

Ram RR, Mendiratta S, Bodemann BO, Torres MJ, Eskiocak U, White MA.

Mol Cell Biol. 2014 Jun;34(12):2350-8. doi: 10.1128/MCB.01506-13. Epub 2014 Apr 14.

9.

Human melanoma metastasis in NSG mice correlates with clinical outcome in patients.

Quintana E, Piskounova E, Shackleton M, Weinberg D, Eskiocak U, Fullen DR, Johnson TM, Morrison SJ.

Sci Transl Med. 2012 Nov 7;4(159):159ra149. doi: 10.1126/scitranslmed.3004599.

10.

Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation.

Kim SB, Pandita RK, Eskiocak U, Ly P, Kaisani A, Kumar R, Cornelius C, Wright WE, Pandita TK, Shay JW.

Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):E2949-55. doi: 10.1073/pnas.1207718109. Epub 2012 Oct 8.

11.

RNAi screening of the human colorectal cancer genome identifies multifunctional tumor suppressors regulating epithelial cell invasion.

Ly P, Eskiocak U, Parker CR, Harris KJ, Wright WE, Shay JW.

Cell Res. 2012 Nov;22(11):1605-8. doi: 10.1038/cr.2012.140. Epub 2012 Oct 9. No abstract available.

12.

Short hairpin RNA screen indicates that Klotho beta/FGF19 protein overcomes stasis in human colonic epithelial cells.

Kim J, Eskiocak U, Stadler G, Lou Z, Kuro-o M, Shay JW, Wright WE.

J Biol Chem. 2011 Dec 16;286(50):43294-300. doi: 10.1074/jbc.M111.267641. Epub 2011 Oct 21.

13.

Processive and distributive extension of human telomeres by telomerase under homeostatic and nonequilibrium conditions.

Zhao Y, Abreu E, Kim J, Stadler G, Eskiocak U, Terns MP, Terns RM, Shay JW, Wright WE.

Mol Cell. 2011 May 6;42(3):297-307. doi: 10.1016/j.molcel.2011.03.020.

14.

Functional parsing of driver mutations in the colorectal cancer genome reveals numerous suppressors of anchorage-independent growth.

Eskiocak U, Kim SB, Ly P, Roig AI, Biglione S, Komurov K, Cornelius C, Wright WE, White MA, Shay JW.

Cancer Res. 2011 Jul 1;71(13):4359-65. doi: 10.1158/0008-5472.CAN-11-0794. Epub 2011 Apr 28.

15.

Characterization of aneuploid populations with trisomy 7 and 20 derived from diploid human colonic epithelial cells.

Ly P, Eskiocak U, Kim SB, Roig AI, Hight SK, Lulla DR, Zou YS, Batten K, Wright WE, Shay JW.

Neoplasia. 2011 Apr;13(4):348-57.

16.

CDDO-Me protects against space radiation-induced transformation of human colon epithelial cells.

Eskiocak U, Kim SB, Roig AI, Kitten E, Batten K, Cornelius C, Zou YS, Wright WE, Shay JW.

Radiat Res. 2010 Jul;174(1):27-36. doi: 10.1667/RR2155.1.

PMID:
20681796
17.

Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro.

Roig AI, Eskiocak U, Hight SK, Kim SB, Delgado O, Souza RF, Spechler SJ, Wright WE, Shay JW.

Gastroenterology. 2010 Mar;138(3):1012-21.e1-5. doi: 10.1053/j.gastro.2009.11.052. Epub 2009 Dec 4.

PMID:
19962984
18.

hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.

Sakin V, Eskiocak U, Kars MD, Iseri OD, Gunduz U.

Exp Oncol. 2008 Sep;30(3):202-5.

PMID:
18806742
19.

Effect of doxorubicin on telomerase activity and apoptotic gene expression in doxorubicin-resistant and -sensitive MCF-7 cells: an experimental study.

Eskiocak U, Işeri OD, Kars MD, Biçer A, Gunduz U.

Chemotherapy. 2008;54(3):209-16. doi: 10.1159/000140464. Epub 2008 Jun 18.

PMID:
18560228
20.

Label-free detection of telomerase activity using guanine electrochemical oxidation signal.

Eskiocak U, Ozkan-Ariksoysal D, Ozsoz M, Oktem HA.

Anal Chem. 2007 Nov 15;79(22):8807-11. Epub 2007 Oct 11.

PMID:
17927276

Supplemental Content

Loading ...
Support Center